Douglas M Haselwood Inc Roseville, CA - 95661

Douglas M Haselwood Inc is categorized under Rheumatologists in Roseville, CA and active since 1986.

Douglas M Haselwood Inc was established in 1986, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Ericka Tullock, Office Manager at the company’s single location by writing to 151 North Sunrise Avenue # 1201, Roseville, California CA 95661 or by phoning (916) 677-4744. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Douglas M Haselwood Inc
Contact Person: Ericka Tullock, Office Manager
Address: 151 North Sunrise Avenue # 1201, Roseville, California 95661
Phone Number: (916) 677-4744
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1986
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Rheumatologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Douglas M Haselwood Inc was started in 1986 to provide professional Rheumatologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Ericka Tullock, Office Manager for inquiries that concern Douglas M Haselwood Inc by calling the company number (916) 677-4744, as your correspondence is most welcome. Additionally, the physical location of the single location of Douglas M Haselwood Inc can be found at the coordinates 38.74798,-121.26271 as well as the street address 151 North Sunrise Avenue # 1201 in Roseville, California 95661.

For its online presence, you may visit Douglas M Haselwood Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.